arrow
L

Lucia Nichelli

la pitié salpétrière hospital
H指数:13
被引数:537

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gliomas with pleomorphic and pseudopapillary features (GPAP) are circumscribed tumors with targetable mutations, prolonged survival, and frequent tumor predisposition

具有多形性和假乳头状特征的胶质瘤(GPAP)是边界清晰的肿瘤,具有可靶向的突变、生存期延长和频繁的肿瘤易感性

2026-09-300
OAAI
Plasma proteomics for prognostic stratification in newly diagnosed primary central nervous system lymphoma

血浆蛋白质组学在 newly diagnosed primary central nervous system lymphoma 患者预后分层中的应用

2026-09-230
PRE
Diagnostic Accuracy of APTw and NOEw MRI Metrics for IDH Mutation and 1p/19q Codeletion Prediction in Gliomas

APTw和NOEw MRI指标在预测胶质瘤中IDH突变和1p/19q共缺失的诊断准确性

2026-09-220
OAAI
La suppression du signal liquidien améliore la précision de l’imagerie APTw pour la stratification moléculaire des gliomes

液体信号抑制提高了APTw成像在胶质瘤分子分层中的精度。

2026-02-240
PRE
Tandem combination of ASCT and CAR T-cell therapy in highly refractory CNS lymphomas

ASCT与CAR T细胞疗法串联联合治疗高度难治性CNS淋巴瘤

2025-08-310
OAAI
Resistance of recurrent epidermal growth factor receptor-altered glioblastoma to anti-epidermal growth factor receptor targeted therapy with osimertinib

复发性表皮生长因子受体变异型胶质母细胞瘤对奥希替尼靶向表皮生长因子受体的抗性

2025-07-010
OAAI
Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: An ancillary study from the BLOCAGE trial

肠道微生物组调节接受化疗的原发性中枢神经系统淋巴瘤患者的结局:一项来自BLOCAGE试验的附加研究

2025-03-060
PRE